These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2534779

  • 41. [Presymptomatic diagnosis in Huntington chorea families using the gene amplification technique].
    Lucotte G, Berriche S, Petit MC, Burckel A, Turpin JC.
    Rev Neurol (Paris); 1991; 147(8-9):602-4. PubMed ID: 1835796
    [Abstract] [Full Text] [Related]

  • 42. Comparative neuropsychological study of the changes in different programmed activities in subjects with frontal or retro-rolandic lesions or with Huntington's chorea.
    Girotti F, Sghirlanzoni A, Massetto N, Caraceni T.
    Encephale; 1978; 4(4):371-81. PubMed ID: 154397
    [Abstract] [Full Text] [Related]

  • 43. [Specific enzymatic amplification of a DNA region closely associated with Huntington chorea].
    Novelli G, Mandich P, Ruzzo A, Mannello F, Ajmar F, Dallapiccola B.
    Boll Soc Ital Biol Sper; 1990 May; 66(5):419-25. PubMed ID: 2144430
    [Abstract] [Full Text] [Related]

  • 44. Huntington disease: a detective story.
    Schaefer FV, Floyd M, Say B.
    J Okla State Med Assoc; 1992 May; 85(5):223-6. PubMed ID: 1387416
    [Abstract] [Full Text] [Related]

  • 45. Attitudes of neurologists, psychiatrists, and psychotherapists towards predictive testing for Huntington's disease in Germany.
    Thies U, Bockel B, Bochdalofsky V.
    J Med Genet; 1993 Dec; 30(12):1023-7. PubMed ID: 8133501
    [Abstract] [Full Text] [Related]

  • 46. Electrophysiological measures as potential biomarkers in Huntington's disease: review and future directions.
    Nguyen L, Bradshaw JL, Stout JC, Croft RJ, Georgiou-Karistianis N.
    Brain Res Rev; 2010 Sep; 64(1):177-94. PubMed ID: 20381528
    [Abstract] [Full Text] [Related]

  • 47. Attitudes of those at risk for Huntington's disease toward presymptomatic provocative testing.
    McCormack MK, Lazzarini A.
    N Engl J Med; 1982 Nov 25; 307(22):1406. PubMed ID: 6215584
    [No Abstract] [Full Text] [Related]

  • 48. Use of L-dopa in the detection of presymptomatic Huntington's chorea.
    Klawans HL, Paulson GW, Ringel SP, Barbeau A.
    N Engl J Med; 1972 Jun 22; 286(25):1332-4. PubMed ID: 4260358
    [No Abstract] [Full Text] [Related]

  • 49. [Early and presymptomatic detection of Huntington chorea].
    Leblhuber F.
    Fortschr Neurol Psychiatr; 1993 Jan 22; 61(1):1-21. PubMed ID: 8440509
    [Abstract] [Full Text] [Related]

  • 50. Different options for prenatal testing for Huntington's disease using DNA probes.
    Fahy M, Robbins C, Bloch M, Turnell RW, Hayden MR.
    J Med Genet; 1989 Jun 22; 26(6):353-7. PubMed ID: 2525622
    [Abstract] [Full Text] [Related]

  • 51. Prenatal diagnosis for Huntington's disease: a molecular and psychological study.
    Spurdle A, Kromberg J, Rosendorff J, Jenkins T.
    Prenat Diagn; 1991 Mar 22; 11(3):177-185. PubMed ID: 1674823
    [Abstract] [Full Text] [Related]

  • 52. Predictive testing for Huntington's disease with linked DNA markers.
    Brock DJ, Mennie M, Curtis A, Millan FA, Barron L, Raeburn JA, Dinwoodie D, Holloway S, Crosbie A, Wright A.
    Lancet; 1989 Aug 26; 2(8661):463-6. PubMed ID: 2570183
    [Abstract] [Full Text] [Related]

  • 53. The Tiresias complex: Huntington's disease as a paradigm of testing for late-onset disorders.
    Wexler NS.
    FASEB J; 1992 Jul 26; 6(10):2820-5. PubMed ID: 1386047
    [Abstract] [Full Text] [Related]

  • 54. Motor changes in presymptomatic Huntington disease gene carriers.
    Siemers E, Foroud T, Bill DJ, Sorbel J, Norton JA, Hodes ME, Niebler G, Conneally PM, Christian JC.
    Arch Neurol; 1996 Jun 26; 53(6):487-92. PubMed ID: 8660148
    [Abstract] [Full Text] [Related]

  • 55. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers.
    Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, Foroud T.
    Arch Neurol; 1999 May 26; 56(5):563-8. PubMed ID: 10328251
    [Abstract] [Full Text] [Related]

  • 56. Ethics of predictive testing for Huntington's chorea: the need for more information.
    Craufurd DI, Harris R.
    Br Med J (Clin Res Ed); 1986 Jul 26; 293(6541):249-51. PubMed ID: 2942216
    [Abstract] [Full Text] [Related]

  • 57. Unimpaired verbal memory and oculomotor control in asymptomatic adults with the genetic marker for Huntington's disease.
    Rothlind JC, Brandt J, Zee D, Codori AM, Folstein S.
    Arch Neurol; 1993 Aug 26; 50(8):799-802. PubMed ID: 8352663
    [Abstract] [Full Text] [Related]

  • 58. Low utilization of prenatal and pre-implantation genetic diagnosis in Huntington disease - risk discounting in preventive genetics.
    Schulman JD, Stern HJ.
    Clin Genet; 2015 Sep 26; 88(3):220-3. PubMed ID: 25307798
    [Abstract] [Full Text] [Related]

  • 59. First-trimester prenatal diagnosis for Huntington's disease with DNA probes.
    Hayden MR, Hewitt J, Kastelein JJ, Langlois S, Wilson RD, Fox S, Hilbert C, Bloch M.
    Lancet; 1987 Jun 06; 1(8545):1284-5. PubMed ID: 2884412
    [Abstract] [Full Text] [Related]

  • 60. Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker.
    Quarrell OW, Meredith AL, Tyler A, Youngman S, Upadhyaya M, Harper PS.
    Lancet; 1987 Jun 06; 1(8545):1281-3. PubMed ID: 2884411
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.